LINC01569/miR-4722-5p/RAB14调节轴在慢性阻塞性肺病相关炎症中的作用及其临床价值分析
Guangfei Xu1, Na Wang2, Jianying Wang3
1Geriatrics Department, Nantong Hospital of Traditional Chinese Medicine, Nantong, China.
Journal of biochemical and molecular toxicology
|January 15, 2026
概括
研究人员确定了一种涉及LINC01569,miR-4722-5p和RAB14的新型调节途径,该途径影响慢性阻塞性肺病 (COPD) 的进展和炎症. 这一途径显示出作为预测COPD发展和恶化的生物标志物的巨大潜力.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性阻塞性肺病 (COPD) 由于微妙的早期症状,存在诊断挑战.
- 识别新的生物标志物对于有效的COPD预防和管理至关重要.
- 竞争性内源性RNA (ceRNA) 网络为疾病调节提供了潜在的机制.
研究的目的:
- 使用生物信息学探索具有预测价值的COPD相关的ceRNA机制.
- 确定一个特定的监管轴,并验证其在COPD病原和炎症中的作用.
- 评估COPD患者中确定的分子的临床意义和预测潜力.
主要方法:
- 使用公共数据库 (基因表达总汇,lncRNASNP2,miRDB) 构建与COPD相关的ceRNA网络.
- 生物信息分析包括路径分析 (基因和基因组的京都百科全书) 和统计建模 (逻辑回归,ROC曲线).
- 实验验证使用RNA下拉,双化酶记者测定和基于细胞的模型 (使用香烟烟雾提取物的BEAS-2B细胞) 的实验验证.
主要成果:
- 确定了一个LINC01569/miR-4722-5p/RAB14 ceRNA轴,其中LINC01569通过海绵化miR-4722-5p.p.促进RAB14表达,从而促进RAB14表达.
- 在COPD急性恶化 (AECOPD) 中,LINC01569和RAB14被上调,并作为具有高预测准确度 (AUC > 0.82) 的风险因素.
- miR-4722-5p作为AECOPD发生的保护因子 (AUC = 0.724),其表达与炎症标志物相关联.
结论:
- LINC01569/miR-4722-5p/RAB14轴是影响COPD进展和炎症的关键ceRNA机制.
- 这一轴具有重要的潜力,可以作为COPD发展和恶化的预测生物标志物.
- 针对这种调节轴可能为COPD相关的炎症提供治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K


